Quantamental Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History

Quantamental Technologies’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-798	Closed	-$656K	–	617
2023 Q1	$656K	Buy	+798	New	+$602K	0.35%	82
2022 Q1	–	Sell	-1,364	Closed	-$861K	–	529
2021 Q4	$861K	Buy	+1,364	New	+$839K	0.44%	59
2021 Q2	–	Sell	-674	Closed	-$319K	–	270
2021 Q1	$319K	Buy	+674	New	+$328K	1.02%	46
2020 Q4	–	Sell	-647	Closed	-$362K	–	240
2020 Q3	$362K	Sell	647 -380	-37%	-$230K	0.27%	114
2020 Q2	$640K	Buy	+1,027	New	+$583K	0.43%	79
2019 Q4	–	Sell	-819	Closed	-$227K	–	1131
2019 Q3	$227K	Sell	819 -223	-21%	-$66K	0.07%	458
2019 Q2	$326K	Buy	+1,042	New	+$347K	0.12%	282

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantamental Technologies's REGN Position: Q2 2023 in Review

Quantamental Technologies sold out of Regeneron Pharmaceuticals (REGN) in Q2 2023, closing a stake of 798 shares — an estimated $656K sold.

Quantamental Technologies first reported a position in REGN in Q2 2019 and held it in 7 quarters. The position peaked at $861K in Q4 2021. 1,165 funds tracked by Wall St. Rank hold REGN as of Q2 2023.

Quantamental Technologies reported no remaining Regeneron Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
Quantamental Technologies sold 798 Regeneron Pharmaceuticals shares in Q2 2023, an estimated $656K.
Quantamental Technologies first reported a position in Regeneron Pharmaceuticals in Q2 2019 and held it in 7 quarters.
Quantamental Technologies's Regeneron Pharmaceuticals position peaked at $861K in Q4 2021.
1,165 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2023.

Based on Quantamental Technologies's 13F filing for Q2 2023, filed 14 Aug 2023.